» Articles » PMID: 22568954

Profiling Eph Receptor Expression in Cells and Tissues: a Targeted Mass Spectrometry Approach

Overview
Journal Cell Adh Migr
Specialty Cell Biology
Date 2012 May 10
PMID 22568954
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The Eph receptor tyrosine kinase family includes many members, which are often expressed together in various combinations and can promiscuously interact with multiple ephrin ligands, generating intricate networks of intracellular signals that control physiological and pathological processes. Knowing the entire repertoire of Eph receptors and ephrins expressed in a biological sample is important when studying their biological roles. Moreover, given the correlation between Eph receptor/ephrin expression and cancer pathogenesis, their expression patterns could serve important diagnostic and prognostic purposes. However, profiling Eph receptor and ephrin expression has been challenging. Here we describe a novel and straightforward approach to catalog the Eph receptors present in cultured cells and tissues. By measuring the binding of ephrin Fc fusion proteins to Eph receptors in ELISA and pull-down assays, we determined that a mixture of four ephrins is suitable for isolating both EphA and EphB receptors in a single pull-down. We then used mass spectrometry to identify the Eph receptors present in the pull-downs and estimate their relative levels. This approach was validated in cultured human cancer cell lines, human tumor xenograft tissue grown in mice, and mouse brain tissue. The new mass spectrometry approach we have developed represents a useful tool for the identification of the spectrum of Eph receptors present in a biological sample and could also be extended to profiling ephrin expression.

Citing Articles

EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation.

Offenhauser C, Dave K, Beckett K, Smith F, Jayakody B, Cooper L Oncogene. 2024; 44(4):208-227.

PMID: 39511410 PMC: 11753358. DOI: 10.1038/s41388-024-03206-x.


Canonical ligand-dependent and non-canonical ligand-independent EphA2 signaling in the eye lens of wild-type, knockout, and aging mice.

Horner J, Vu M, Clark J, Innis I, Cheng C Aging (Albany NY). 2024; 16(20):13039-13075.

PMID: 39466050 PMC: 11552635. DOI: 10.18632/aging.206144.


Targeting the EphA2 pathway: could it be the way for bone sarcomas?.

Giordano G, Tucciarello C, Merlini A, Cutrupi S, Pignochino Y Cell Commun Signal. 2024; 22(1):433.

PMID: 39252029 PMC: 11382444. DOI: 10.1186/s12964-024-01811-7.


Transmembrane helix interactions regulate oligomerization of the receptor tyrosine kinase EphA2.

Wirth D, Ozdemir E, Wimley W, Pasquale E, Hristova K J Biol Chem. 2024; 300(7):107441.

PMID: 38838777 PMC: 11263659. DOI: 10.1016/j.jbc.2024.107441.


Lipidation and PEGylation Strategies to Prolong the Half-Life of a Nanomolar EphA4 Receptor Antagonist.

Gomez-Soler M, Olson E, de la Torre E, Zhao C, Lamberto I, Flood D Eur J Med Chem. 2024; 262.

PMID: 38523699 PMC: 10959496. DOI: 10.1016/j.ejmech.2023.115876.


References
1.
Gale N, Holland S, Valenzuela D, Flenniken A, Pan L, Ryan T . Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 1996; 17(1):9-19. DOI: 10.1016/s0896-6273(00)80276-7. View

2.
Fox B, Tabone C, Kandpal R . Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines. Biochem Biophys Res Commun. 2006; 342(4):1263-72. DOI: 10.1016/j.bbrc.2006.02.099. View

3.
Olivieri G, Miescher G . Immunohistochemical localization of EphA5 in the adult human central nervous system. J Histochem Cytochem. 1999; 47(7):855-61. DOI: 10.1177/002215549904700702. View

4.
Shao H, Lou L, Pandey A, Pasquale E, Dixit V . cDNA cloning and characterization of a ligand for the Cek5 receptor protein-tyrosine kinase. J Biol Chem. 1994; 269(43):26606-9. View

5.
Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T . Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem. 2004; 50(3):490-9. DOI: 10.1373/clinchem.2003.026849. View